Author

Sergey S. Markin

Observed names: S Markin, S S Markin, S. S Markin, S. S. Markin, S.S. Markin, Sergey Markin, Sergey S Markin, С. С. Маркин

Institutions: SuperGen (United States), Institute of Biomedical Chemistry

Observed institutions: Sechenov University, Ministry of Health of the Russian Federation, Federal Research and Clinical Center of Physical-Chemical Medicine named after Y.M. Lopukhin, SuperGen (United States), Institute of Biomedical Chemistry

ORCID: 0000-0002-0242-0282

Observed ORCID: 0000-0002-0242-0282

OpenAlex ID: A5058426137

Nonimmunogenic staphylokinase in the treatment of acute ischemic stroke (FRIDA trial results)

2022 · E.I. Gusev, M.Yu. Martynov, et al. · S S Korsakov Journal of Neurology and Psychiatry · 32

High-Density Lipoproteins as Homeostatic Nanoparticles of Blood Plasma

2020 · Vasily A. Kudinov, Olga Yu. Alekseeva, et al. · International Journal of Molecular Sciences · 29

PDF

High-density lipoprotein remodeling by phospholipid nanoparticles improves cholesterol efflux capacity and protects from atherosclerosis

2021 · Vasily A. Kudinov, Tatiana I. Torkhovskaya, et al. · Biomedicine & Pharmacotherapy · 22

PDF

Non-immunogenic recombinant staphylokinase versus alteplase for patients with massive pulmonary embolism: a randomized open-label, multicenter, parallel-group, non-inferiority trial, FORPE

2024 · Alexander I. Kirienko, Stanislav G. Leontyev, et al. · Journal of Thrombosis and Haemostasis · 16

PDF

Advanced results of Fortelyzin® use in the FRIDOM1 study and real clinical practice

2022 · V. A. Markov, D. V. Duplyakov, et al. · Russian Journal of Cardiology · 15

PDF

Targeted metabolomic profiling of acute ST-segment elevation myocardial infarction

2024 · Sergey S. Markin, E. A. Ponomarenko, et al. · Scientific Reports · 14

PDF

Thrombolysis With the Non-Immunogenic Staphylokinase for Acute Ischemic Stroke in the FORPI Registry: An Observational Study

2025 · Nikolay A. Shamalov, Mikhail Yu Martynov, et al. · Stroke · 12

Prevention of cerebral vasospasm and delayed cerebral ischemia in patients with massive aneurysmal subarachnoid hemorrhage

2019 · V. V. Krylov, A. V. Prirodov, et al. · Russian journal of neurosurgery · 11

PDF

Metabolomic Diagnostics and Human Digital Image

2019 · Elena E Balashova, Petr G Lokhov, et al. · Personalized Medicine · 11

Assessment of the allergenic and immunotoxic properties of the recombinant non-immunogenic staphylokinase in preclinical and clinical trials

2025 · S. S. Markin, S. V. Ivanov, et al. · Pharmacy & Pharmacology · 10

PDF

A novel preliminary metabolomic panel for IHD diagnostics and pathogenesis

2024 · S. S. Markin, E. A. Ponomarenko, et al. · Scientific Reports · 10

PDF

Dysfunctional High-Density Lipoproteins: Role in Atherogenesis and Potential Targets for Phospholipid Therapy

2018 · T. I. Torchovskaya, V. A. Kudinov, et al. · Kardiologiia · 10

PDF

Study of the pharmacokinetics of non-immunogenic staphylokinase in patients with acute myocardial infarction and acute ischemic stroke

2025 · S. V. Ivanov, I. P. Beletsky, et al. · Pharmacy & Pharmacology · 9

PDF

Non-immunogenic staphylokinase — a thrombolytic agent in the treatment of massive pulmonary embolism: results of the FORPE clinical trial

2024 · A. I. Kirienko, S. G. Leontyev, et al. · Russian Journal of Cardiology · 9

PDF

Thrombolytic therapy of ischemic stroke

2018 · E. I. Gusev, M. Yu. Martynov, et al. · S S Korsakov Journal of Neurology and Psychiatry · 9

Non-immunogenic staphylokinase in patients with massive intermediate-high risk pulmonary embolism: protocol of the FORPE-2 multicenter, double-blind, randomized, placebo-controlled trial

2025 · S. N. Tereshchenko, E. B. Yarovaya, et al. · Russian Journal of Cardiology · 7

Metabolomic Markers for Predicting Preeclampsia in the First Trimester of Pregnancy: A Retrospective Study

2022 · Ekaterina V. Ilgisonis, Raisa Shalina, et al. · Molecules · 7

PDF

Non-Immunogenic Staphylokinase vs Alteplase in Patients with Massive Pulmonary Embolism: the Protocol of a Multiple-Center Open-Label Randomized Trial FORPE

2022 · A.I. Kirienko, E.B. Yarovaya, et al. · Journal of Venous Disorders · 7

Human CHR18: “Stakhanovite” Genes, Missing and uPE1 Proteins in Liver Tissue and HepG2 Cells

2021 · K.A. Deinichenko, G.S. Krasnov, et al. · Biomedical Chemistry Research and Methods · 7

High Density Lipoproteins Phosphatidylcholine as a Regulator of Reverse Cholesterol Transport

2018 · T. I. Torkhovskaya, V. A. Kudinov, et al. · Russian Journal of Bioorganic Chemistry · 7

Ldl-Apheresis on Affine Haemosorbents

1990 · Yu. M. Lopukhin, V. V. Zuevsky, et al. · Biomaterials Artificial Cells and Artificial Organs · 7

Nebulized Non-Immunogenic Staphylokinase in the Mice Acute Lung Injury Model

2022 · Sergey S. Markin, Roman D. Lapshin, et al. · International Journal of Molecular Sciences · 6

PDF

Fortelyzin for acute ischaemic stroke treatment: an open, prospective, non-interventional, observational study FORPI registry

2025 · N.A. Shamalov, M.Yu. Martynov, et al. · S S Korsakov Journal of Neurology and Psychiatry · 5

Safety of prehospital thrombolysis with non-immunogenic staphylokinase in 51021 patients with ST-elevation myocardial infarction: data from the FRIDOM-registry

2025 · S. N. Tereshchenko, S. F. Bagnenko, et al. · Russian Journal of Cardiology · 5

PDF

Ultra-small phospholipid nanoparticles in the treatment of combined hyperlipidemia: a randomized placebo-controlled clinical trial

2024 · Alexander Archakov, Valery Kukharchuk, et al. · Research in Pharmaceutical Sciences · 5

Works count: 63

Citation count: 337

H-index: 10

I10-index: 12